Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approachOA
To the Editor:Cholangiocarcinomas(CCAs)are heterogeneous group of malignancies,encompassing intrahepatic CCA(iCCA),and extrahepatic CCA(eCCA);they are also classified into common hepatic duct cholangiocarcinoma(CHDCCA),choledocus extrapancreatic cholangiocarcinoma(EPCCA)and choledocus intrapancreatic cholangiocarcinoma(IPCCA)and,finally,gallbladder carcinoma(GBCCA).CCAs are relatively uncommon but.
Paola Parente;Valentina Angerilli;Giuseppe Zamboni;Angelo Sparaneo;Fabiola Fiordelisi;Leonarda Di Candia;Matteo Fassan;Paolo Graziano;
Pathology Unit,Fondazione IRCCS Casa Sollievo della Sofferenza,71013,San Giovanni Rotondo(Foggia),ItalyDepartment of Medicine(DIMED),Surgical Pathology Unit,University of Padua,35128,Padua(Padua),ItalyPathology Unit,IRCCS Ospedale Sacro Cuore Don Calabria,37024,Negrar(Verona),ItalyLaboratory of Oncology,Fondazione IRCCS Casa Sollievo della Sofferenza,71013,San Giovanni Rotondo(Foggia),ItalyDepartment of Medicine(DIMED),Surgical Pathology Unit,University of Padua,35128,Padua(Padua),Italy Veneto Institute of Oncology IOV-IRCCS,35124,Padua(Padua),Italy
临床医学
carcinomagallbladderNrf2
《Hepatobiliary & Pancreatic Diseases International》 2024 (003)
P.317-321 / 5
This study was supported by a grant from the Italian Ministry of Health,Ricerca Corrente Program 2016-2018 to Paola Parente.
评论